California Case Summaries

Shannon Standridge, et al. v. Island Hospitality Management, LLC, et al. — Hotel Defendants’ Third-Party Indemnity and Contribution Claims Against Insulin Pump Maker Dismissed With Leave to Amend for Inadequate Defect Allegations

Unreported / Non-Citable

Case
Shannon Standridge, et al. v. Island Hospitality Management, LLC, et al.
Court
U.S. District Court — Southern District of California
Judge
Thomas J. Whelan (Bill Clinton, 1998)
Date Decided
2026-11-18
Docket No.
3:25-cv-02285
Status
Unreported
Topics
Federal Rule of Civil Procedure 14, impleader, comparative equitable indemnity, equitable contribution, strict products liability, manufacturing defect, Rule 12(b)(6) plausibility

Background

Plaintiff Shannon Standridge, a pediatric neurologist with type 1 diabetes attending a San Diego medical conference, suffered acute respiratory failure and severe hypoxic brain injury after hotel staff at the Moxy Hotel San Diego allegedly failed to perform a promised wellness check. Standridge and her husband brought a diversity negligence action against hotel operator Island Hospitality Management, LLC and hotel owner WS 831 Sixth Owner LLC, alleging that hotel staff's delayed response to her husband's urgent warnings caused permanent cognitive deficits.

The hotel defendants filed a third-party complaint under Federal Rule of Civil Procedure 14 against Beta Bionics, Inc., the manufacturer of Standridge's iLet Bionic Pancreas automated insulin delivery system, seeking equitable indemnity and contribution under California law. The hotel operators alleged that Beta Bionics was a joint tortfeasor because responding paramedics obtained a blood glucose reading of 'low' while Standridge's iLet device displayed 'hi.' Beta Bionics moved to dismiss under Rule 12(b)(6), and the hotel defendants opposed while requesting leave to plead strict products liability and add a direct claim for property damage.

The Court’s Holding

The district court granted the motion to dismiss with leave to amend, holding that the hotel defendants failed to plead a plausible basis for Beta Bionics' tort liability. Under California law, equitable indemnity and contribution require viable underlying tort liability to the plaintiff. The court determined that alleging a bare discrepancy between two glucose readings did not plausibly show a manufacturing or design defect, because the pleading failed to allege which reading was inaccurate, that the device misread glucose during critical hours, that it delivered unneeded insulin, or that the issue stemmed from a product defect rather than user error or calibration.

The court rejected Beta Bionics' argument that statutory contribution claims cannot be brought before entry of a joint money judgment under California Code of Civil Procedure § 875, ruling that Federal Rule of Civil Procedure 14(a)(1) governs federal impleader and permits asserting inchoate, unaccrued contribution claims. The court granted 21 days' leave to amend the third-party claims, but denied without prejudice the hotel operators' request to add a direct damages claim, holding that direct claims cannot be added informally in an opposition brief without a formal motion under Local Rule 15.1(b).

Key Takeaways

  • Third-party claims for equitable indemnity or contribution under California law require plausible factual allegations demonstrating predicate tort liability owed to the underlying plaintiff.
  • Alleging a discrepancy between two medical monitor readings without facts showing device malfunction, erroneous insulin delivery, or a product defect fails Rule 12(b)(6) plausibility standards.
  • Federal Rule of Civil Procedure 14(a)(1) permits impleading third parties on inchoate, contingent contribution claims before a joint money judgment is rendered under state law.
  • Affirmative direct damage claims cannot be introduced through an opposition brief and require a formal motion with a proposed amended pleading under Civil Local Rule 15.1(b).

Why It Matters

This decision underscores that third-party plaintiffs attempting to shift tort liability to a medical device manufacturer must plead concrete factual links establishing how the product malfunctioned and caused the plaintiff's injuries. Additionally, the ruling confirms that Rule 14 impleader controls the timing of contingent contribution claims in federal court, allowing defendants to bring in prospective joint tortfeasors before state-law statutory accrual requirements are met.

Read the full opinion (PDF) · Court docket

Scroll to Top